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Abstract  
The biological response of strontium (Sr) doped hydroxyapatite (HA) and hydroxyapatite-
zirconia (HA-ZrO2) composites produced by employing sol-gel technology, minimal ZrO2 
loadings and novel microwave sintering regimes thereby retarding decomposition, is 
reported.  In vitro evaluations indicate that all materials induce a favourable response from rat 
osteosarcoma cells (ROS).  In vivo evaluations show osteoconductivity and biocompatibility 
for both the Sr-HA and HA-ZrO2.  The materials did not cause any inflammatory response in 
bone.  The Sr-HA displays better biocompatibility which may be a due to the incorporation of 
Sr and the formation of a surface apatite layer. 
 
 
 
 
  
1. Introduction 
We report the biological response of novel nano Sr-HA and HA-ZrO2 composites designed 
for load bearing applications in the skeleton produced by employing sol-gel technology, 
minimal ZrO2 loadings and novel microwave sintering regimes, thereby retarding 
decomposition (1,2).  Three composites were evaluated in vitro using rat osteosarcoma (ROS) 
cells; a reproducible method of determining the response of cells in culture to test 
biomaterials (3).  The two most promising materials were then further evaluated to assess the 
bone response to the test materials in a rat femur healing model (4).   
HA is employed for repairing skeletal defects as it resembles the mineral phase of bone and is 
bioactive.  However, its poor strength limits load-bearing applications.  Mechanical 
properties can be improved by incorporating zirconia, but sintering at high temperature is 
required, resulting in HA decomposition and reduced bioactivity (5,6).  At a critical point of 
dehydroxylation the process becomes irreversible and the HA begins to decompose to other 
calcium phosphates (7).  Decomposition produces products such as tetracalcium phosphate 
[TTCP]{Ca4(PO4)2O} which can further degrade to tri-calcium phosphate [TCP]{Ca3(PO4)2} 
(8) and calcium oxide.  In addition, studies of the stability of HA show that the presence of 
ZrO2 serves to destabilise the HA structure at lower temperatures than would be seen without 
the oxide phase (9,10,11,12). 
Sr
2+
 has a biological role in the body where it decreases the activity of bone resorbing 
osteoclasts and increases the activity of bone forming osteoblasts (13,14).  In the HA lattice,  
Sr
2+
 replaces the cation Ca
2+
, but due to the mismatch in atomic radii there is a lattice 
expansion (15,16) affecting the properties of the material.  The presence of Sr
2+
 within HA is 
known to decrease the mechanical resistance of the ceramic in a linear manner (17); and may 
also increase the solubility of Sr-HA compared to HA.  This increase in the solubility of the 
Sr-HA has been reported to have a positive effect on osteoblasts and reduce the number of 
osteoclasts due to the release of Sr
2+
 (18).  In addition to Sr
2+
 release, increased Ca
2+
 release 
from Sr-HA is suggested to activate calcium channels and thus stimulate cell response (19).  
Also, increased solubility of the Sr-HA increases the possibility of increased interconnected 
porosity on its surface enhancing osseintegration (20,21) and interfacial bonding (22).  Thus, 
although Sr-HA is a more resorbable material than HA, its possible increase in bioactivity 
and bonding to bone make it a more desirable material that could influence the quality of 
newly formed bone. 
Zirconia exists in three different phases depending on temperature; monoclinic (M) at room 
temperature to 1170°C, tetragonal (T) between 1170°C and 2370°C and cubic (C) above this 
temperature (23).  Upon cooling, the T-M transformation results in a volume expansion of 
approximately 4% and the associated stresses can result in cracking of pure zirconia.  The 
addition of “stabilising oxides” such as CaO, MgO, Y2O3 and CeO2 are required to stabilise 
the high temperature C/T phases at room temperature.  The addition of small amounts of 
Y2O3 (2-3 mol%) to zirconia can result in the retention of a fully tetragonal phase at room 
temperature known as tetragonal zirconia polycrystals (TZP) (24).  Yttria stabilized TZP (Y-
TZP) has various inherent characteristics such as low porosity, high density, high bending 
and compression strengths, low coefficient of thermal expansion and chemical stability which 
make it suitable for clinical applications (25).  
The aim of this study was to evaluate the in vivo and in vitro response of these novel Sr-HA 
and HA-ZrO2 composites designed for skeletal load bearing applications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Materials and Methods 
2.1. Materials  
A simple precipitation method previously described by Jarcho et al. (26) was used for the 
HA, which was then modified to produce Sr-HA. 
 
Pure-HA 
Calcium nitrate hydrate (Ca(NO3)2.4H2O) (78.72g) was dissolved in 600ml of distilled water 
which was made basic by the addition of 10ml of ammonium hydroxide (NH4OH).  The 
mixture was stirred vigorously and raised to the desired temperature of 25
o
C under the same 
stirring conditions.  
 
10wt% Sr-HA:  
Ca(NO3)2.4H2O (71.11g) was dissolved in 600ml of distilled water which was made basic by 
the addition of 10ml of NH4OH under vigorous stirring conditions.  Once the Ca(NO3)2.4H2O 
had dissolved, 7.08g of strontium nitrate hydrate (Sr(NO3)2.4H2O) was added to the 
Ca(NO3)2.4H2O and the mixture was raised to the desired temperature of 25
o
C under the 
same stirring conditions.   
 
Di-ammonium hydrogen orthophosphate ((NH4)2HPO4) (26.41g) was made basic in 1066ml 
of water by the addition of 25ml of NH4OH, and brought to the desired temperature of 25
o
C.  
The Ca(NO3)2.4H2O and (NH4)2HPO4 based solutions were stirred vigorously before 
synthesis to ensure the reagents were completely dissolved.  To determine this, visual 
inspection of the solution was conducted for un-dissolved reagent particulates.  Under 
continued vigorous stirring, the (NH4)2HPO4 solution was added drop-wise from a glass 
funnel into the Ca(NO3)2.4H2O solution over a 60 minutes interval.  Throughout the synthesis 
the pH was kept above 10.0 by the addition of NH4OH at constant intervals to avoid a large 
pH change to the system.  Once the drop-wise addition was completed, the solution was kept 
at the synthesis temperature for one hour under the same temperature and vigorous stirring 
conditions, effectively giving an ageing time of one hour.  The sample was then left to stand 
for 24 hours at room temperature.  The supernatant was removed and replaced with fresh 
distilled water, re-stirred for one hour and left to stand again for 24 hours.  This procedure 
was performed three times to remove any unwanted residue from the precipitate.  The 
supernatant was removed a final time and replaced with distilled water and spun for 15 
minutes.  The suspension was then filtered under vacuum, using a Buchner filter and distilled 
water until the ammonia was removed.  The filter cake was then removed from the filter and 
placed into a beaker and dried in a fan assisted oven at 85
o
C for 20 hours.  The dry precipitate 
were then crushed by pestle & mortar and sieved through a 90µm stainless steel sieve. 
 
The sieved HA was mixed with 3 mol% Y2O3 doped ZrO2 (3Y-TZP) (Tosoh Corporation, 
Japan) using a dry ball-milling technique with alumina media for 6 h to create batches of 
composite powders with 5 and 10 wt % ZrO2 additions as described elsewhere [2].  The test 
bodies of Sr-HA and ZrO2-HA were prepared by pressing 1.3g of powder in a 20mm 
diameter stainless steel die.  The green bodies were then densified using a hybrid microwave 
sintering furnace developed at the University of Limerick (Limerick, Ireland).  The device 
has a peak power output of 1.125kW and utilises silicon carbide (SiC) as a susceptor medium 
to facilitate hybrid heating.  Firings were performed at 1200
o
C (±20
o
C) with a hold time of 1 
hour and subsequently left to furnace cool.  
 
HA-A: contained HA doped with 10mol% Sr of the total calcium content.  HA-B: contained 
HA with 5wt% ZrO2 (3Y-TZP), and HA-C: HA with 10wt% ZrO2 (3Y-TZP).  Discs of HA-
A, HA-B and HA-C were 8mm in diameter and 2mm in thickness.  The irregular sized 
granules of HA-A and HA-B were in the range 90-350µm.  The control discs were composed 
of heat cured acrylic. 
 
2.2 X-Ray Diffraction (XRD) 
The HA powder was pressed into ethyl-cellulose pellets using a 32mm ø stainless steel die.  
These were then placed in the X-ray Diffractometer (Philips X’Pert) for an initial scan 
covering a range of 10
o
 to 70
o
 2θ, with a step size of 0.083o and a step time of 120.015 
seconds.  The XRD patterns were then matched to patterns in the JCPDS using the X’Pert 
software. 
 
2.3 X-Ray Fluorescence (XRF) 
XRF is used to determine the chemical composition of a material (Ceram, Stoke-on-Trent, 
UK).  A full report was received along with the calcium to phosphate ratio (Ca/P). 
 
 
2.4 X-Ray Photoelectron Spectroscopy (XPS) 
XPS measurements were done on a Kratos AXIS 165 spectrometer (Kratos Analytical, 
Shimadzu Corporation, Japan) with a monochromatic Al source of spot size 1 mm diameter.  
The X-Ray Gun was run at 150W (10 mA, 15kV) with mono Al Kα of 1486.58 eV.  The Pass 
Energy was 160 eV for survey spectra and 20 eV for narrow regions with a vacuum 
compatibility of 10
-8
 Torr.  The samples were scanned for 50ms (dwell) and 100ms (region) 
with an electron volt energy of 1 eV (dwell) and 0.05 eV (region).  The spectra were collected 
in the normal to the surface direction with a detection limit of 0.1-0.5%.  Construction and 
peak fitting of synthetic peaks in narrow region spectra used a Shirely type background and the 
synthetic peaks were of a mixed Gaussian-Lorenzian type.  Relative sensitivity factors used 
were from the CasaXPS library containing Scofield cross-sections.  RSF values used for 
individual peaks were given in excel sheets, which were used to tabulate and graph the data. 
 
2.5. Cell culture 
Immortalized rat osteosarcoma cells (ROS 17/2.8, Merck Inc.) were cultured in DMEM 
supplemented with 10% (v/v) fetal calf serum (BioSera Ltd., Ringmer, UK), 2mM L-
glutamine, 100 units/ml penicillin, 100 g/ml streptomycin and 250 µg/ml amphotericin B 
(Sigma, Poole, UK).  Cells were incubated at 37C in 5% CO2 in tissue culture flasks and 
passaged by incubating with trypsin-EDTA (Sigma, Poole, UK).   
 
2.6. Alamar Blue assay 
Discs (acrylic, HA-A, HA-B and HA-C) were sterilised in 70% (v/v) ethanol, before being 
washed in PBS three times and placed into 24 well plates.  ROS cells (1 x 10
4
 ) were added 
onto the discs and incubated at 37C in 5% CO2.  After 48 or 72 hours the media was 
replaced with media containing 10% alamar blue, covered with foil and incubated.  After 4 
hours the fluorescence (λex = 540 nm, λem = 585 nm) was measured using an Infinite M200 
plate reader with Magellan Software (Tecan, Switzerland). 
 
2.7. DNA Quantification 
Cells were lysed by repeated freeze thawing using molecular biology grade water and the 
amount of DNA was quantified using a fluorescent DNA Quantification Kit (Sigma).  
Briefly, unknown DNA samples were mixed with 2 µg/ml bisBenzimide H33258 solution 
and the fluorescence (λex = 360 nm, λem = 460 nm) was measured using an Infinite M200 
plate reader with Magellan Software (Tecan, Switzerland).  These readings were then 
compared to standard curves to determine the amount of DNA in the samples. 
 
2.8. Scanning electron microscopy (SEM) 
Discs were fixed in 2.5% glutaraldehdye in 0.1 M phosphate buffer overnight at 4C, washed 
three times in 0.1 M phosphate buffer and fixed in 2% aqueous osmium tetroxide for 2 hours 
at room temperature.  Specimens were then dehydrated through a graded series of ethanol at 
room temperature and air dried overnight.  Once dry, samples were mounted on stubs, 
attached with Sticky Tabs, and coated with approximately 25 nm of gold in an Edwards 
S150B sputter coater.  Specimens were examined in a Phillips/FEI XL-20 SEM at an 
accelerating voltage of 20Kv. 
 
2.9. Surgery 
Juvenile male Wistar rats aged 4-6 weeks at the time of surgery were used for this study.  
Animals were housed in groups in conventional laboratory conditions and provided with 
standard laboratory food and water ad-libitum. 
 
Animals were anaesthetised using Isoflurane in oxygen; under aseptic conditions the mid-
shaft of the right femur was exposed using sharp and blunt dissection and a defect created 
using a 1mm diameter round stainless steel dental bur running at slow speed in a dental 
handpiece under saline irrigation.  Approximately 4 - 8 granules (90-350µm) of a single test 
material were placed into the bone defect using fine tweezers, (n=6 per material). 
 
Wounds were closed using resorbable sutures at 28 days.  Animals were sacrificed using a 
schedule one method.  The right femurs were dissected free and placed in formalin.  The 
femurs were demineralised in formic acid and processed to paraffin embedded sections 
stained with haematoxylin and eosin.  Evaluation of the bone response was carried out using 
conventional light microscopy. 
 
2.10. Statistical Analysis  
The differences between groups were analysed by the Mann-Whitney U test (GraphPad Prism 
version 5.01 for Windows, GraphPad Software, San Diego, CA, www.graphpad.com).  The 
results were considered statistically significant at a P value of  0.05 
3. Results  
 
3.1 Powder characterisation 
The stoichiometric quality of the laboratory produced HA was investigated using XRD and 
XRF analysis techniques.  XRD analysis matched the laboratory synthesised HA to JCPDS 
card 09-0432 while the XRF results determined the Ca/P ratio to be 1.66.  From these results 
it was determined that the HA synthesis procedure produces near stoichiometric quality HA.  
The ratio of Ca
2+
 to Sr
2+
 was determined using XPS as 19.43% to 1.99% respectively in the 
Sr-HA with 10% Sr
2+
 substituted for the total Ca
2+
 content.  This ratio of 20:2 indicates that 
the there was near total substitution of the Sr
2+
 ions into the HA lattice in place of the Ca
2+
 
ions. 
 
3.2. Cell Viability (Incubation with Alamar Blue)  
Initially at 48 hours, differences were seen in cell viability when comparing cells grown on 
the test materials and tissue culture plastic (100%).  Cells grown on HA C (74%; p,0.01) were 
the least viable followed by HA B (85%; p,0.01) and then HA A (90%; p<0.05).  However, 
after 72 hours of culture these differences were less marked and there was no significant 
difference in cell viability between all of the test materials (Figure 1). 
  
a.  
 
 
b. 
 
 
Figure 1. % Cell viability a) after 48 hours and b) 72 hours compared to cells grown on 
tissue culture plastic (100%).  Mean ± SEM, n = 6 discs, + p < 0.05, ++ p < 0.01, ** p < 0.01 
compared to tissue culture plastic control, Mann-Whitney) 
 
 
 
3.3. DNA Quantification  
DNA quantification showed that there was no significant difference between cells grown on 
acrylic and cells grown on the test materials after 48 and 72 hours (Figure 2).  After 72 hours, 
there was a significant difference in the amount of DNA between cells grown on HA A and 
cells grown on HA B or HA C (p<0.01) 
 
a. 
 
 
b. 
 
Figure 2 Amount of DNA a) after 48 hours and b) 72 hours. Mean ± SEM, n = 6 discs, * p < 
0.05, ** p < 0.01, Mann-Whitney. 
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3.4. Qualitative Examination: SEM 
The initial appearance of the materials surface prior to exposure to culture media, the effect 
of incubation with media and exposure to media and ROS cells are shown in figure 3. 
 
Cells migrated onto and colonised all of the materials.  Incubation with culture media alone 
for 72hours had no effect on the surface appearance of acrylic, HA-B and HA-C; however 
there was an alteration in the surface of HA-A with the deposition of a homogeneous 
crystalline layer (Figure 3).  After culture with ROS cells for 72 hours cells had migrated 
onto and attached closely to the surface of all materials and were forming a confluent layer 
which was more complete on the acrylic and HA-A discs (Figure 3). 
 
  
 Figure 3. SEM images of discs (Acrylic, HA-A, HA-B and HA-C) initial appearance, after 
culturing for 72hours with tissue culture media or media and ROS cells (Scale bars 20 µm) 
  
Acrylic Acrylic + Media Acrylic + ROS cells 
 
 
 
 
 
HA A HA A + Media HA A + ROS cells 
 
 
  
HA B HA B + Media HA B + ROS cells 
 
 
  
HA C  HA C + Media HA C + ROS cells 
 
 
 
 
 
 
3.5. Surgery (light microscopy) 
The histological features were similar for both HA-A and HA-B.  At 4 weeks, all surgical 
sites were well healed and the cortical defect was closed and filled with lamellar bone.  In 
some instances, particulate material was seen in this region and was in direct contact with 
bone.  There was no evidence of an inflammatory response in any of the sections examined 
and the materials were well tolerated by bone and marrow tissue.  The granules of material 
were in direct contact with either bone or normal marrow tissue (Figures 4 and 5).  Where 
material was in direct contact with the endosteal bone, the bone was in continuity with the 
material (Figure 4c and 5b), in other areas there was a thin rim of bone around the particles 
(Figure 5b) and sometimes bone bridges between granules (Figure 4b).  There was no 
evidence of resorption of either material.  Where material was seen at the bone / connective 
tissue interface, a thin layer of fibrous connective tissue was seen over the material (Figure 
4c) 
  
 A    
 
  
B 
 
 
C 
 
 
Figure 4 Haematoxylin and eosin stained section of HA-A implanted for 4 weeks into rat 
femora: (a) Low power, scale bar 1 mm, (b) and (c) medium power scale bar 100 µm.  There 
is normal bone (B) and marrow (M) in close contact with HA-A  (arrowed) with bone bridges 
between granules and between HA-A and the endosteal bone. Where material is seen to 
encroach on the overlying periosteal tissue it is covered by a layer of periosteum with no 
evidence of inflammation (P). 
 
 M 
A 
 
 
B 
 
 
Figure 5 Haematoxylin and eosin stained section of HA-B implanted for 4 weeks into rat 
femora: (a) Low power, scale bar 1mm (b) medium power scale bar 100 µm.  There is normal 
bone and marrow in close contact with HA-B (arrowed) with bone encapsulating the granules 
in the marrow space (M). 
 
 
 
 
 
 
 
 
 
M 
4. Discussion 
The in vitro evaluation indicated that all three test materials induced a favourable response in 
the ROS cells with some evidence that the order of “biocompatibility” was: 
HA-A > HA-C ≥ HA-B. 
HA-A may present better biocompatibility due to the variably observed deposition of material 
onto the surface which may have been an apatite layer observed by others on Sr-HA (27).  
Reduced zirconia content has also been reported to be associated with improved bone 
response in HA-ZrO2 composites (28).  HA-A also benefits from the incorporation of 
strontium (29). 
 
The animal model used to assess the bone response to the test materials was the rat femur 
healing model, which is well established; this and the similar rat tibia model have been 
regularly used by our group and others (12,29).  A defect in the immature rat femur will heal 
rapidly and implanted materials will often encourage increased bone formation in the 
medullary space; this region is normally occupied by marrow and has little trabecular bone 
except for the proximal and distal end of the bone.  This model is useful for establishing 
whether a material will elicit a favourable or unfavourable response in bone.  Those that 
excite an unfavourable response in this model are unlikely to be worthy of more long term 
studies.  This model is useful as an early screen for new materials intended for medical 
implantation.  HA-A: (Hydroxyapatite doped with 10mol% Strontium of the total Calcium 
content and HA-B: (HA with 5wt% ZrO2 (3Y-TZP)) both elicited a favourable 
osteoconductive response in bone and would appear suitable for further evaluation in more 
rigorous non healing models.  The materials appears not to have caused any inflammatory 
response in bone, but if excess material were to escape into soft tissue a different response 
may be elicited and care should be taken to interpret these results in the context of bone only. 
 
 
 
 
 
5. Conclusion 
 In vitro evaluation indicated that all three test materials induced a favourable response 
in the ROS cells, the order of ‘biocompatibility’ was HA-A>HA-C≥HA-B 
 HA-A may have better biocompatibility due to incorporation of strontium and the 
formation of a surface layer on exposure to simulated body fluid – tissue culture 
media. 
 In vivo evaluation showed both HA-A and HA-B materials to be osteoconductive and 
biocompatible in the model used.   
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